A point mutation in a highly conserved region of the/3~ subunit, Asp ~3~ to Ala (D130A) substitution, abrogates the Arg-Gly-Asp (RGD)-dependent binding of ot5/3~ to fibronectin (FN) without disrupting gross structure or heterodimer assembly. The D130A mutation also interferes with binding to invasin, a ligand that lacks RGD sequence. In spite of the lack of detectable FN binding by cts/3~(D130A), it was recruited to adhesion plaques formed on FN by endogenous hamster receptors. Thus, intact ligand binding function is not required for recruitment of c~5/3~ to adhesion plaques. Overexpression of/3~(D130A) partially interfered with endogenous tXsl3~ function, thus defining a dominant negative/3~ integrin mutation.
T HE integrins comprise a family of at least six heterodimers of cell surface receptors which share common/3t subunits but have distinct o~ subunits. They recognize multiple ligands (for review see Hemler, 1990) including fibronectin (FN) ~, laminin, collagen, epiligrin (Carter et al., 1991) , invasin , and vascular cell adhesion molecule-1 (Elices et al., 1990) , and mediate cell-cell and cell-extracellular matrix interactions. The identification of the ligand binding domain of/3~ integrins is important for understanding their functions. Chemical cross-linking studies of Arg-Gly-Asp (RGD)-containing peptides to the RGD-dependent t33 integrins, platelet ~r0~33 (GPIlb-llIa) and o~vt33 (vitronectin receptor), have shown that RGD-containing peptide cross-links to residues 109-171 of/33 of Ot~ro/33 (D'Souza et al., 1988) , and to an overlapping region (residues 61-203) of the/33 of o~v/33 (Smith and Cheresh, 1988 ). In addition,/33 of C~ro/33 from a thrombasthenic patient has a point substitution at Asp u9 to Tyr, which inactivates ot~rd3~ binding to fibrinogen (Loftus et al., 1990) , underscoring the importance of this region in ligand-/33 integrin interaction.
Based on the high similarity of this region (residues 109-171 of/3t) among integrin 13 subunits, especially the smaller region consisting of residues 108-127 (76 and 81%, respectively), compared to overall similarity (•45%), we hypothesized that the corresponding region in/3~ is also involved in the ligand-/3~ integrin interaction. To address this hypothesis, we examined the effects of the substitution of Asp ~3~ of/3~ (which corresponds to the Asp H9 in/33) to Ala (D130A substitution) on t~5/3t functions, ots/3~ binds to the 110K cell binding domain of FN in an RGD-dependent manner (Pytela et al., 1985) , as well as to invasin, a protein in-1. Abbreviations used in this paper: DHFR, dihydrofolate reductase; FN, fibronectin; MBP-Inv479, maltose binding protein-invasin fusion protein.
volved in the entry of the bacterial cells into eukaryotic cells . The affinity of ot5/3~ for invasin is two orders of magnitude higher than for FN (Isberg, 1991; Nrhieu and Isberg, 1991) . In addition, the COOH-terminal 192 amino acid residues of invasin, which contain the integrin binding region, do not contain RGD sequence.
We report here that the D130A substitution in the /3~ subunit blocks the binding of c~513~ both to the FN ll0K cell binding fragment and to invasin. Overexpression of /31(D130A) interfered with the endogenous ot5/31 function. Furthermore, ligand-binding defective /3~(D130A) was assembled into the adhesion plaques formed in transfected cells cultured on Fn, suggesting that intact ligand binding is not essential for the recruitment of this receptor to existing adhesion plaques.
Materials and Methods

Materials
FN was purified from fresh human plasma by using gelatin Sepharose (Engval and Ruoslahti, 1977; Plow et al., 1979) . FN I10K fragment was obtained by chymotryptic digestion of FN and subsequent gelatin-Sepharose and Sephacryl S-200 gel filtration chromatographies (Pierschbacher et al., 1982) . MBP-Inv479 was prepared by using pJL309 plasmid in Escherichia coli MC1000 which was provided by R. Isberg (Tufts University, Boston, MA) . FN IlOK fragment and MBP-Inv479 was coupled to CNBr-activated Sepharose (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) at 2.4 and 2.0 mg/ml packed volume, respectively, according to the manufacturer's instructions. PMSF and octyl-/3-D-glucopyranoside were purchased from Caibiochem Corp. (La Jolla, CA) . N-Ethylmaleimide was purchased from Sigma Chem. Co. (St. Louis, MO), and Na125I from Amersham Corp. (Arlington Heights, IL).
mAb 7E2 (to hamster/30 and PB1 (to hamster cts) Juliano, 1985, 1988) were from R. L. Juliano (University of North Carolina, Chapel Hill, NC). mAbs to human ~i were obtained from the following sources: AlAS from M. E. Hemler (Dana-Farber Cancer Institute, Boston, MA); mAbl3 (Akiyama et al., 1989 ) from K. Yamada (NIH, Washington, DC); LM534 (Cheresh et al., 1989 ) from D. Cheresh (The Scripps Research In-stitute), and QE.2E5 (Faull, 1991) from R. Faull (The Scripps Research Institute). 102DF5 was prepared as described (Yliinne and Virtanen, 1989) . Goat anti-human ~1 antiserum (antibody 172) was prepared by immunizing a goat with purified human a4/~l preparation, and recognizes human but not hamster #1. Anti-denatured ~1 antiserum (cross-reactive to both human and hamster/~t) was prepared by immunizing rabbits with the SDSdenatured at/31 preparation purified from human placenta (Takada et al., 1987) . The serum recognizes human al and/31, and mouse and hamster fit. Anti-a3 cytoplasmic peptide antibody (reactive to human, mouse, and chicken a3 [Solowska et al., 1989; Takada et al., 1991] ) and anti-as cytoplasmic peptide antibody were obtained from E. Mareantonio (Massachusetts Institute of Technology, Cambridge, MA). The anti-denatured human a4 antibody (reactive to human and mouse a4 [Holzman et al., 1989] ), was prepared as described (Hemler et al., 1987; . The anti-c~2 cytoplasmic peptide antibody was prepared as described .
Construction of ~l cDNA Expression Vector and Mutagenesis
The human ~1 cDNA clone (B-3) was cloned from human endothelial Xgtll library (obtained from T. Collins, Brigham and Women's Hospital, Boston, MA) with partial/31 cDNA (obtained from E. Ruoslahti, La Jolla Cancer Research Foundation, La Jolla, CA) as probe. The clone B-3 (•3.55 kb) includes a 2,334-bp complete coding region, and 58-bp 5'-noneoding and 1,100-bp 3'-noncoding regions. The amino acid sequence deduced from the nucleotide sequence of the clone B-3 was the same as the published sequence (Argraves et al., 1987) except that His 92 was Thr and Thr 19s was Ser in clone B-3. Oligonucleotide-direeted mutagenesis of/~1 eDNA clone B-3 in pBluescript KS+ was carded out using a combination of the primer extension method (Zoller and Smith, 1982) , and the method of Kunkel et ai. (1987) with synthetic oligonucleotide, 5'-ACTACCTTATGGCCCTGT-CTTATTC-3' (YLMALSYS) based on the published/~1 sequence 5'-ACT-ACCTTATGGACCTGTCTTATTC-3' (YLMDLSYS) as primer. The whole coding region of the mutagenized eDNA was sequenced and the absence of other mutations was confirmed. The wild-type/~1 or mutagenized #~ (D130A) eDNA in pBluescript was digested with XbaI (XbaI site is in the vector) and NheI (NheI site is in a 3' noneoding region in eDNA). After gel purification, the 2.9-kb XbaI/NheI fragment containing whole coding region was ligated to XbaI-digested/caif intestinal phosphatase-treated pCDneo vector (Aruffo and Seed, 1987) .
Transfection and Amplification of the
Transfected Gene
DG44 cells, a dihydrofolate reductase (DHFR)-deficient mutant of CHO cell line (Urlaub and Chasin, 1980 ) (obtained from L. A. Chasin, Columbia University, NY), were maintained in the a-modified minimal essential medium (a-minus MEM, Sigma Chem. Co.) supplemented with 10% heatinactivated FCS, hypoxanthine, and thymidine in a 5 % CO2 incubator at 37~ ~1 or /31(D130A) cDNA in pCDneo vector (10 /~g) and 1 /~g of pLTRdhfr26 plasmid (Subramani et ai., 1981) (obtained from Amer. Type Culture Collection, Rockville, MD) were cotransfected into DG44 cells (107 cells) by electroporation. Transfected cells were maintained for 3 d in the above medium, and then transferred to a-minus MEM supplemented with 10% dialyzed FCS and 700/~g/ml G418 (Gibco Laboratories, Grand Island, NY). After 10-14 d, resulting colonies were harvested and cells expressing human/3x were collected by sorting with mAb A1A5 in FACStar (Becton Dickinson Immunocytometry Sys., Mountain View, CA). mAb AlAS reacts with both human/31 and/31(D130A) (Fig. 1, e and f). The transfected genes were then amplified in a-minus MEM supplemented with 10% dialyzed FCS, 700 #g/ml G418, and the increasing concentration (up to 100 nM) of the DHFR inhibitor methotrexate (Kaufman and Sharp, 1982) .
FN IIOK Fragment-Sepharose Affinity Chromatography
Cells were harvested by washing the attached cells with PBS (0.15 M NaC1, 10 mM potassium phosphate, pH 7.4) twice and incubating in 3.5 mM EDTA in PBS at room temperature for 3 rain, and washed twice with PBS. Cells ("~ • 106) were then surface labeled with t25I by using iodogen (Pierce Chem., Rockford, IL) (Braciale et ai., 1986) , washed three times with PBS, and solubilized in 0.4 ml of 100 mM octyl-/3-D-glucopyranoside in 10 mM Tris-HCl/0.15 M NaC1 (TBS), 1 mM MnC12, 1 mM PMSE 1 mM N-ethylmaleimide, pH 7.4, at 4~ for 1 h. The insoluble materials were
Log fluorescence intensity removed by centrifugation at 15,000 g for 10 min. The supernatant was then incubated with a small amount of underivatized Sepharose 4B at 4~ for 1 h to remove nonspecific binding material. The supernatant was incubated with 1 ml of packed FN ll0K fragment-Sepharose at 4~ overnight, which had been equilibrated with TBS containing 1 mM MnCI2, i mM PMSF, 1 mM N-ethylmaleimide, 25 mM octyl-~-D-glucopyranoside, pH 7.4 (washing buffer). The unbound materials were washed with 20 ml of washing buffer and the bound materials were eluted with 20 mM EDTA instead of 1 mM MnC12 in washing buffer, and 2.5-ml fractions were collected. 0.25-ml aliquots of the peak fraction (2.5 ml) of the eluted radioactivity were used for immunoprecipitation. The samples were precleared by incubating with protein G-Sepharose and immunoprecipitated as described below.
Maltose Binding Protein-Invasin Fusion Protein (MBP-Inv479)-Sepharose Affinity Chromatography
The MBP-Inv479-Sepharose affinity chromatography was carried out as described above for FN ll0K-Sepharose chromatography except that (a) 50 /~1 packed volume of MBP-Inv479-Sepharose was used, (b) unbound materials were removed by washing three times in 1 ml of washing buffer, and (c) 500/~1 of 20 mM EDTA in washing buffer was used for elution.
Immunoprecipitation of CeU Extracts
Cells were 12sI surface-labeled, and washed as described above and solubilized in 1 ml of 20 mM Tris, 0.15 M NaCI, 1% Triton X-100, 0.05% Tween 20, pH 7.4, containing 2 mM PMSF, 10 mM benzamidine HC1, 5 U/ml trasylol, and 0.02 % NaN3 (IPB), and incubated on ice for 1 h and centrifuged at 15,000 g for 10 min. The supernatant was precleared by incubating with protein G-Sepharose (Pharmacia LKB Biotechnology Inc.) for 30 min at 4~ and incubated with antibody for 1 h at room temperature. The immune complex was recovered by incubating with protein G-Sepharose for 30 min at 4~ washed three times with 1 ml IPB, boiled for 5 min in 50 #1 of SDS-PAGE sample buffer, and analyzed by SDS-PAGE (7% gel) (Laemmli, 1970) under nonreducing conditions.
Adhesion of CeUs to FN-coated Plates
Wells of the Immulon 2 removable 96-well plates (Dynatech Labs., Inc., Chantilly, VA) were incubated with 100 #1 of PBS containing different concentrations of FN overnight at 4~ The other protein binding sites were blocked by incubating with 100 #1 of 1% BSA for 30 min at room temperature, and wells were washed twice with PBS. Cells were harvested with TPCK trypsin (Worthington Biochem. Corp., Freehold, NJ), 3.5 mM EDTA in PBS, washed once with 0.5 mg/ml soybean trypsin inhibitor (Sigma Chem. Co.), and washed twice with incubation buffer (137.5 mM NaCl, 12 mM NaHCO3, 2.6 mM KC1, 5 mM Hepes, 5 mM glucose, 2 mM CaC12, 0.1% BSA). 3 x 106 cells in 200/zl incubation buffer were incubated with 50 #Ci NaStCr (12.5-25 Ci/mmol, Amersham Corp.) for 1 h at 37~ and washed three times with incubation buffer. 4 x 104 cells (100 /xl) were added to each well and incubated for 1 h at 37~ The wells were washed three times with incubation buffer and then bound radioactivity was counted in a ~/counter.
Indirect Immunofluorescence Microscopy
Cells were harvested with 0.05 % trypsin, 0.5 mM EDTA (Irvine Scientific, Santa Ana, CA); washed once with tx-minus MEM supplemented with 10% FCS, hypoxanthine, and thymidine; and then twice with the medium minus serum. Round glass coverslips were coated overnight at 4"C with 20/zg/ml of FN in PBS; then the other protein binding sites were blocked by incubating with 1% BSA for 30 rain at room temperature. The harvested cells were plated onto the coverslips in the medium minus serum, incubated for 4 h at 37~ and then fixed with methanol for 10 min in -20~ The number of spreading cells were counted from three high power microscopic fields (28-144 cells were counted in each field). The fixed cells were incubated with the primary antibodies, and then with FITC-coupled goat anti-mouse IgG ('lhgo, Inc., Budingame, CA), for 30 min at room temperature. The stained cells were observed in an Axiophot fluorescent microscope (Carl Zeiss, Inc., Oberkochen, Germany).
Results
Expression and Characterization of H u m a n 131 or 131(D13OA) in C H O Cells
The /3~ or /3~(D130A) c D N A was transfected into C H O cells. After selection by resistance to G418 and D H F R § phenotype, human/3t or/3~(D130A) expression was further amplified by using increasing methotrexate, a D H F R inhibitor, concentration in the medium. Human/3~ or/3~(D130A) was expressed at levels approximately equal to that of endogenous hamster /3~ in C H O cells (Fig. 1) . Both /31 and /3~(D130A) were recognized by four other anti-human /31 mAbs, in addition to A 1 A 5 -m A b l 3 , LM534, QE.2E5, and 1 0 2 D F 5 -b u t none of these m A b s recognized the endogenous hamster/31 (data not shown).
Immunoprecipitations of the ~25I surface-labeled cell extracts (Fig. 2) showed that the human/31 or/3t(D130A) (Mr -6) 1/) and t3~(D130A)-CHO (lanes 15 and 17) . Antidenatured /3~ recognized both hamster Bt and human t3t//Jt(D130A) (lanes 4, 10, and 16). Antibody 172 recognized human/3J/3ffD130A) but not hamster B~ (lanes 5, 11, and 17).
We undertook studies to identify the ot subunit associated with the recombinant human /3~//3~(D130A). CHO ceils contain aSBl as the major/31 integrin species with a small amount of ot3/3t (Giancotti and Ruoslahti, 1990 ). o~5-deficient CHO cells lose ,~80% of /3t integrin expression (Schreiner et al., 1989) , and CHO cells express similar quantities of ot~ and/~ (Fig. 1) . Consistent with these, c~ or a2 (which are larger in size than other a subunits) was not detected in CHO cells by immunoprecipitation with anti431 (Fig. 2) or anti-c~2 cytoplasmic peptide antibody (Fig. 4, lanes 15 and 21) . To determine whether the transfected human /31 or B~(D130A) is associated with a5 and/or c~3, extracts of surface ~2SI-labeled transfected cells were immunopurified with human /3~-specific mAb A1A5 immobilized to Sepharose. The recovered recombinant/Jr integrins were solubilized and then reimmunoprecipitated with antibodies that react with multiple species ~ subunits. The anti-as cytoplasmic domain antibody precipitated the ot subunit associated with human/3t or c~5/~(D130A) were passed through immobilized FN l l0K (central cell-binding domain) affinity columns as described in Materials and Methods. 250-/~1 aliquots of the peak EDTA-eluted fraction (2.5 ml) from the FN ll0K Sepharose column with/3~ (lanes 1-7) or B~(D130A) (lanes 8-14) CHO extract, or the peak pass-through fraction (2.5 ml) with/31 (lanes 15-20) or/31(D130A) (lanes 21-26) CHO extract were analyzed by immunoprecipitation with anti-human/3~ polyclonal (172) (lanes 3, 10, 16 and 22) or monoclonal A1A5 (lanes 4, 11, 17 and 23) antibodies; anti-hamster t~5 monoclonal (PB1) (lanes 5 and 12); anti-hamster/31 monoclonal (7E2) (lanes 6, 13, 18 and 24); anti-denatured/3~ (nonspecies-specific) polyclonal (lanes 7, 14, 19 and 25); or irrelevant polyclonal antibody (antiintegrin ct2 cytoplasmic domain) (lanes 2, 9, 15 and 21). The EDTA-eluted material (20 #1 each) from the FN ll0K-Sepharose with/Jr-or/31(D130A)-CHO extract were also analyzed without immunoprecipitation (lanes 1 and 20, and 8 and 26, respectively). The samples were analyzed by SDS-PAGE (7% gel) under nonreducing conditions. (Lanes 1-14) The EDTA eluate from/31-CHO contained hamster c~5 and O~, and human/3~. The eluate from the/3,(DI30A)-CHO contained hamster or5 and/3~, but no human/31(D130A). (Lanes 15-26) The human ~3t and B~(D130A) were present in the unbound fractions.
The Journal of Cell Biology, Volume 119, I992while the anti-~ and anti-o~4 antibodies did not produce detectable immunoprecipitates (Fig. 3) . Thus, the recombinant human ~, or ~(D130A) was associated with endogenous hamster o~s.
a~[3~(DI3OA ) Does Not Bind to FN IIOK Fragment
The previous experiments established that both human/~ and/3~(D130A) were expressed as heterodimers with hamster o~. Since FN is a major ligand for ot~#~, we assessed the binding of these recombinants to the immobilized cell binding domain of FN. When extracts of surface ~2~I-labeled CHO cells bearing recombinant/31 integrins were subjected to FN ll0K affinity chromatography, the bound fraction (EDTA eluate) contained only two ~2~I-labeled protein bands corresponding to c~ and 151 subunits in size (Mr 150K and ll0K, nonreduced) (Fig. 4, lanes 1 and 8, for ~t-CHO and ~(D130A)-CHO cells, respectively). Immunoprecipitation of the EDTA eluate (Fig. 4) showed that the eluate from ~:CHO contained hamster o~ (lane 5) and hamster (lane 6) and human (lanes 3 and 4) ~. The eluate from the ~(D130A)-CHO contained hamster o~ (lane 12) and ~ Oane 13), but no human/3~(D130A) (lanes 10 and 11) . The human ~ and /3~(D130A) were detected in the unbound fractions by immunoprecipitation (Fig. 4, lanes 16 and 17;  22 and 23, respectively) . Thus, c~B~(D130A) had no detectable affinity for the FN ll0K fragment.
~d3~(D13OA) Does Not Bind to Invasin
FN binding to otsfll depends on the RGD sequence in the 10th type HI repeat (Pytela et al., 1985; Pierschbacher et al., 1982; Obara et al., 1988) . To determine whether the D130A substitution abolished binding to a ligand that lacks RGD, we assessed the binding of ots~(D130A) to invasin. The ~25I surface-labeled cell extracts were incubated with MBPInv479-Sepharose in the presence of Mn :+. SDS-PAGE analysis of the EDTA eluted materials detected two bands corresponding to c~ and ~ in size (Fig. 5) . The EDTA eluates were analyzed by immunoprecipitation (Fig. 5, bottom) . (Bottom) The bound fraction (Fig. 5, top) from ~ (lanes 1-5) or Bt(D130A) (lanes 6-10) immunoprecipitated with preimmune rabbit serum (lanes 2 and 7); antibody 172 (lanes 3 and 8); mAb 7E2
(lanes 4 and 9); and anti-denatured/3t (lanes 5 and 10). 20 #1 each of the EDTA fraction from/3,-or B~(D130A)-CHO ceils was analyzed without immunoprecipitation in lanes 1 and 6, respectively. Samples were analyzed by SDS-PAGE (7% gel) under nonreducing conditions.
Overexpression of ~z(D130A ) Produces Dominant Negative Effects
~(D130A) forms a binding-defective heterodimer with endogenous or5 and may, therefore, block cell functions dependent on ots/~. To test this possibility, the adhesion of/~I-CHO or/~(D130A)-CHO cells to FN was examined (Fig.  6 ). The ~(D130A)-CHO cells were less adherent to FN than the ~-CHO or parent CHO cells (the amount of FN required for 50% of cells to adhere was 0.2 #g/well for ~(D130A)-CHO cells and 0.1 #g/well for the others), reflecting the decrease in functional as/~t on the surface. At higher FN concentration (2 #g/well), the difference in adhesion among parent, B~-CHO, and #t(D130A)-CHO cells is relatively small. However, only 7.4 + 1.5% of adhering /3~(DI30A)-CHO cells spread in contrast to 56 + 7.5 and 46 5: 8.1% of adherent CHO and ~-CHO cells, respectively. Fig. 7 shows the striking difference in morphology between human /~ and /3~(D130A) CHO cells on FN (2 #g/well). Thus, overexpression of ~(D130A) reduces the function of endogenous as/~. The ratio of expression of B1(D130A) mutant to endogenous wild-type ~ integrin in /$~130A)-CHO cells was ",,2:1 based on the mean fluorescent intensity (Fig. 1) . 
Binding-defective Human ~(DI3OA ) Is Assembled into Adhesion Plaques on FN
As noted above, a small percentage of ~t(DI30A)-CHO cells spread on FN. To determine whether this ligand binding-defective mutant could be recruited to adhesion plaques formed by endogenous hamster t~5~, we localized the human/3~ or ~t(D130A) in the transfectants that spread on the FN-coated glass coverslips (Fig. 8) . In/3~-CHO cells, hamster /~ (mAb 7E2, b) and human /3t (mAbs 102DF5, e; QE.2E5, h; A1A5, k; LM534, data not shown) were localized in the adhesion plaques. In the spreading/~(D130A)-CHO cells, human /3~(D130A) mutant was present in the adhesion plaques as detected by three antihuman/3~ mAbs (102DFS, f; QE.2E5, i; LM534, data not shown). This staining was specific for human/31, since these three antibodies did not stain the hamster/3t-containing adhesion plaques formed by untransfected CHO cells (Fig. 8, d and g; data not shown for LM534). Surprisingly, the antihuman ~1, A1A5 did not stain the plaques in the/3~(D130A)-CHO cells (Fig.  8 l) . Essentially, the same results were obtained also with CHO cells transiently expressing human/3~ or/3t(D130A) subunit on the surface after 48 h of transfection (data not shown). These findings indicate that/3~(D130A) mutant can be recruited to adhesion plaques formed by hamster c~5/3,.
Discussion
This paper establishes that a point mutation in a highly conserved region of the/~ subunit (Asp ~3~ to Ala substitution) abrogates the RGD-dependent binding of t~5/3~ to FN, and that the substitution also interferes with the recognition of invasin that lacks the RGD sequence, suggesting that the Asp 13~ is critical in multiple ligand-o~5/~ interactions. The Asp '3~ to Ala substitution of/3~ does not result in a major structural change in the whole ~ molecule because (a) ~](D130A) was expressed on the surface of CHO cells in association with endogenous o~5 subunits, and (b) five mAbs against human ~l recognize ~(D130A). Thus, the D130A mutation in ~ abrogates a5/3~ ligand binding function without disrupting gross structure or heterodimer assembly. Asp ~3~ of/3~ corresponds to Asp ~' 9 of ~3, a residue reported to be critical in ligand (fibrinogen) binding to ot~n,/3a (Loftus et al., 1990) . Since the protein ligands of Ol~rd3a contain RGD sequences, it is noteworthy that u5~(D130A) failed to recognize invasin, a ligand which lacks the RGD sequence . Nevertheless, the binding of invasin to ol5/3~ is inhibited by RGD peptide (Nhieu and Isberg, 1991) . Taken together, these data are consistent with a common ligand binding mechanism for integrins irrespective of the presence of the RGD sequence in the ligand. The high degree of conservation of the sequence surrounding Asp ~3~ is consistent with such a mechanism (Loftus et al., 1990) .
Although a5/3~(D130A) was ligand binding defective, it was recruited into adhesion plaques on FN. This suggests that integrins can be recruited to adhesion plaques without binding ligands. Clustering of individual receptors and organization thereafter occurred only when cells were exposed to the specific ligand and the clustering preceded the association of vinculin with adhesion plaques and stress fiber formation (Dejana et al., 1988) . Chicken B] lacking cytoplasmic domain does not enter adhesion plaques; however, it does bind to FN, suggesting that interaction with cytoskeletal components is necessary for the localization of the receptors to adhesion plaques (Solowska et al., 1989) . Therefore, one possible sequence of events in the localization of receptor in adhesion plaques is (a) the interaction of the receptor with the specific matrix protein ligand, (b) clustering of the specific receptor species, and then (c) the interaction with cytoskeletal components. One possible explanation for the localization of binding-defective ots/3~(D130A) in adhesion plaques is that the initial interaction of intact hamster ~5/3~ with FN induces clustering of the receptors, including both as~] and oLs~(D130A), leading to the incorporation of the ~L(D130A) into adhesion plaques. Consistent with this, LaFlamme et al. (1992) suggested that fl~ cytoplasmic domain has enough information to target Otsfll to existing adhesion plaques, since IL-2 receptor with/3~ cytoplasmic domain was recruited to existing adhesion plaques on FN. However, we could not rule out the possibility that there could be some interaction of the asfl~(D130A) with FN, leading to FN-dependent conformational changes, which allow for the recruitment of fl~(D130A) to focal adhesions. LaFlamme et al. (1992) also suggested that the ligand occupancy regulates the redistribution of the receptor via conformational change that unmasks the fl~ cytoplasmic domain or regions of the cytoplasmic domain that interact with specific cytoskeletal proteins, since RGD peptide promoted the recruitment of o~sfl~ into adhesion plaques on laminin, an irrelevant ligand. Because ligand binding-defective c~fll-(D130A) was recruited to adhesion plaques, it might have a conformation similar to that of a ligand-occupied form.
/3~(D130A) is detected in adhesion plaques of the transfected CHO cells cultured on FN with four different anti- human/32 mAbs but, not with mAb A1A5. One possible explanation of this data is that A1A5 epitope in t31 is related to a site of receptor-receptor interaction during clustering and, therefore, its epitope is not accessible to antibody in adhesion plaques formed in 131(D130A)-CHO cells because recruitment of/31(D130A) to adhesion plaques is dependent on interactions that shield the epitope. In contrast, wild-type human i31 may also be recruited by ligand binding and may express accessible A1A5 epitopes.
The ability to delete ~31 integrins would be very helpful for defining their roles in adhesion, migration, differentiation, metastasis, transformed phenotype, or signal transduction. Almost all cell lines express/31 integrins in various combinations (for review see Hemler, 1990) . While it is theoretically possible to make such deletions of t32 in the germline of mice (Capecchi, 1989) , deletion of/31 may be lethal as in Drosophila (Mackrell et al., 1989) . It is clear that dominant negative receptor mutants can provide insights into receptor function in vivo (Amaya et al., 1991; Ueno et al., 1991) ./31(D130A) is dominant negative since it forms nonfunctional heterodimers with endogenous a~, leading to suppression of the endogenous t3t integrin function. In the present study, the partial dominant-negative effects by the mutant 131(D130A) was seen at the ratio of mutant-to-wild-type/31 expression of ~ 2:1 based on the mean fluorescent intensity, suggesting that the level of/31 integrins expression is just enough to support adhesion and spreading on matrix protein in CHO cells. If the/3~(D130A) is overexpressed in cells with less endogenous t31 integrins (e.g., lymphocytic cells) instead of fibroblastic CHO cells, higher mutant-to-wildtype ratio and therefore more complete dominant negative effects may be obtained. This suggests that tissue-specific ex- pression of dominant-negative/~(D130A) in transgenic animals will provide a powerful means to assess the role of/31 integrins in the development and function of differentiated tissues.
